FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia - Medscape

Submitted by Anonymous (not verified) on Wed, 09/01/2021 - 15:49

FDA Approves First Twice-Yearly Antipsychotic for Schizophrenia  Medscape